@romina_iranmanesh's GHK-Cu claims don't match the science

What does this creator actually claim?

Romina Iranmanesh tells her 13.9K Instagram followers that GHK-Cu peptide delivers dramatic benefits beyond skin care. She lists angiogenesis, mitochondrial optimization, nerve repair, systemic anti-inflammatory effects, antioxidant activity, and gene expression changes.

The post features a lab rat reference (complete with Ratatouille hashtags) and includes a disclaimer that GHK-Cu is research-only. But the underlying message is clear: this peptide is supposedly a biological Swiss Army knife that works throughout your body.

She's positioning GHK-Cu as far more than a cosmetic ingredient, suggesting it has profound physiological effects.

Does the research actually support these claims?

The evidence is much weaker than Iranmanesh suggests. Most GHK-Cu studies use cell cultures or animal models, not humans taking peptide supplements.

Pickart et al. (2012) found GHK-Cu increased collagen synthesis in cultured fibroblasts by 70%. A small 2015 study by Arul et al. showed faster wound healing in 20 patients using topical GHK-Cu cream. But these don't prove systemic effects from oral or injectable peptides.

The angiogenesis claims trace back to a 2004 study by Sen et al. that used extremely high concentrations (10-50 μM) in lab dishes. Real-world peptide dosing rarely achieves these levels in tissues.

For "mitochondrial optimization" and "gene expression modulation," the studies exist but they're preliminary. Kang et al. (2009) found some gene expression changes in cultured cells, but translating cell culture results to human physiology is notoriously unreliable.

What's wrong with this presentation?

Iranmanesh jumps from limited laboratory studies to sweeping health claims without acknowledging the massive gaps in evidence. She doesn't mention that most research uses topical applications, not the systemic forms popular in peptide communities.

The "lab rat" framing is cute but misleading. Actual lab studies on GHK-Cu use doses and delivery methods that don't match how people typically use peptides.

Her disclaimer about research-only use contradicts the confident tone of her benefit claims. You can't simultaneously say something is proven effective and only for research.

The bigger issue: she presents preliminary findings as established facts. Cell culture studies don't predict human responses reliably, especially for complex processes like "mitochondrial optimization."

What should you actually know about GHK-Cu?

GHK-Cu is a naturally occurring copper peptide that does show promise for wound healing and skin repair. The compound exists in human plasma at around 200 ng/mL in healthy 20-year-olds, dropping to about 80 ng/mL by age 60.

The strongest evidence supports topical use for skin conditions. Arul et al.'s clinical trial showed 28% faster wound closure with GHK-Cu cream compared to placebo over 10 days.

For systemic effects, we simply don't have adequate human data. The peptide degrades quickly in blood, making sustained tissue levels difficult to achieve through oral or injection routes.

Most commercial GHK-Cu products aren't standardized or tested for purity. The FDA hasn't approved any GHK-Cu supplements, and quality varies dramatically between suppliers.